Niklas Geiger

2PUBLICATIONS
7CO-AUTHORS
Metabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 29, 2026
PYY3-36 potentiates semaglutide-mediated mitochondrial modulation in MASLD.

|Mar 28, 2024
Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats.

Simon Kloock, Niklas Haerting, Gloria Herzog

Pageof 1

Frequent Collaborators

2 joint publications

Vasco Sequeira

1 joint publications

Martin Fassnacht

1 joint publications

Michael Kohlhaas

1 joint publications

Jan Federspiel